US2003170300A1PendingUtilityA1
Combination chemotherapy
Priority: Sep 25, 1998Filed: Oct 8, 2002Published: Sep 11, 2003
Est. expirySep 25, 2018(expired)· nominal 20-yr term from priority
A61P 35/00A61P 35/04A61P 43/00A61P 1/18A61P 13/08A61K 45/06A61K 31/7068A61K 33/24A61K 31/70A61K 31/197A61K 33/243
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Acetyldinaline in combination with gemcitabine, a pharmaceutically acceptable salt thereof, capecitabine, or cisplatin is synergistic for treating cancer.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A combination of antineoplastic agents comprising an antitumor amount of acetyldinaline and an antitumor amount of gemcitabine, a pharmaceutically acceptable salt thereof, capecitabine, or cisplatin.
2 . A combination of claim 1 comprising acetyldinaline formulated as a capsule.
3 . A combination of claim 2 comprising gemcitabine or a pharmaceutically acceptable salt thereof formulated as a sterile solution for intravenous infusion.
4 . A combination of claim 3 comprising gemcitabine monohydrochloride.
5 . A combination of claim 3 comprising gemcitabine monohydrobromide.
6 . A combination of claim 2 comprising cisplatin.
7 . A combination of claim 2 comprising capecitabine.
8 . A method of treating cancer comprising administering to an animal in need of treatment an antitumor amount of a combination of claim 1 .
9 . A method of claim 8 wherein the cancer treated is nonsmall cell lung cancer.
10 . A method of claim 9 comprising administering acetyldinaline in combination with gemcitabine monohydrochloride.
11 . A method of claim 9 comprising administering acetyldinaline in combination with cisplatin.
12 . A method of claim 9 comprising administering acetyldinaline in combination with capecitabine.
13 . A method of claim 8 wherein the cancer treated is prostate cancer.
14 . A method of claim 13 comprising administering acetyldinaline in combination with gemcitabine monohydrochloride.
15 . A method of claim 13 comprising administering acetyldinaline in combination with cisplatin.
16 . A method of claim 13 comprising administering acetyldinaline in combination with capecitabine.
17 . A method of claim 8 wherein the cancer treated is a locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas.
18 . A kit comprising acetyldinaline in one compartment and gemcitabine or a pharmaceutically acceptable salt thereof in a second compartment.
19 . A kit comprising acetyldinaline in one compartment and cisplatin in a second compartment.
20 . A kit comprising acetyldinaline in one compartment and capecitabine in a second compartment.Join the waitlist — get patent alerts
Track US2003170300A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.